Preparing stock dashboard...

Shanghai RAAS Blood Products Co., Ltd.

002252.SZ - Shenzhen - Healthcare - Biotechnology

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.

Data updated June 15, 2026

Price
$4.93

Financial Snapshot

Metric Value ('000,000)
Report Changes

What changed?

Latest period compared with the previous period and the matching prior-year period.

Loading financial changes...

Stock Analysis

Scores this stock using the same metrics model as the compare page.

Metric Value Score
Price & Momentum

Technical Analysis

Calculated locally from stored daily price and volume history.

Loading technical analysis...

Price Chart

Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.